Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Murat Kekilli, Ulku Dagli, Ismail Hakki Kalkan, Bilge Tunc, Selcuk Disibeyaz, Aysel Ulker & Burhan Sahin. (2010) Low incidence of colorectal dysplasia and cancer among patients with ulcerative colitis: A Turkish referral centre study. Scandinavian Journal of Gastroenterology 45:4, pages 434-439.
Read now
Read now
Articles from other publishers (27)
Jian Wan, Xuan Wang, Yujie Zhang, Min Chen, Min Wang, Kaichun Wu & Jie Liang. (2022) Systematic review with meta‐analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low‐grade dysplasia. Alimentary Pharmacology & Therapeutics 55:6, pages 632-644.
Crossref
Crossref
Aaron L. Klinger & Brian R. Kann. (2019) Endoscopy in Inflammatory Bowel Disease. Surgical Clinics of North America 99:6, pages 1063-1082.
Crossref
Crossref
Qing Zhou, Zhao-Feng Shen, Ben-sheng Wu, Cheng-biao Xu, Zhong-qi He, Tuo Chen, Hong-tao Shang, Chao-fan Xie, Si-yi Huang, Yu-gen Chen, Hai-bo Chen & Shu-tang Han. (2019) Risk of Colorectal Cancer in Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice 2019, pages 1-11.
Crossref
Crossref
Afffa Farrukh & John Mayberry. (2019) Evidence of Differences and Discrimination in the Delivery of Care: Colorectal Screening in Healthy People and in the Care and Surveillance of Patients with Inflammatory Bowel Disease. Gastrointestinal Disorders 1:2, pages 253-260.
Crossref
Crossref
Noa Krugliak Cleveland, Nicholas DiNardi & David T. Rubin. 2019. Mastery of IBD Surgery. Mastery of IBD Surgery
255
263
.
Junko Kishikawa, Keisuke Hata, Shinsuke Kazama, Hiroyuki Anzai, Takahide Shinagawa, Koji Murono, Manabu Kaneko, Kazuhito Sasaki, Koji Yasuda, Kensuke Otani, Takeshi Nishikawa, Toshiaki Tanaka, Tomomichi Kiyomatsu, Kazushige Kawai, Hiroaki Nozawa, Soichiro Ishihara, Teppei Morikawa, Masashi Fukayama & Toshiaki Watanabe. (2017) Results of a 36‐year surveillance program for ulcerative colitis‐associated neoplasia in the Japanese population. Digestive Endoscopy 30:2, pages 236-244.
Crossref
Crossref
William A Bye, Tran M Nguyen, Claire E Parker, Vipul Jairath & James E East. (2017) Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database of Systematic Reviews 2017:9.
Crossref
Crossref
M. Rutegård, R. Palmqvist, R. Stenling, J. Lindberg & J. Rutegård. (2016) Efficiency of Colorectal Cancer Surveillance in Patients with Ulcerative Colitis: 38 Years’ Experience in a Patient Cohort from a Defined Population Area. Scandinavian Journal of Surgery 106:2, pages 133-138.
Crossref
Crossref
Ido Laish, Amir Shurani, Olga Barkay, Fred Meir Konikoff & Timna Naftali. (2017) Low prevalence of dysplastic polyps in patients with ulcerative colitis. Clinics and Research in Hepatology and Gastroenterology 41:2, pages 204-209.
Crossref
Crossref
C. Castaño-Milla, M. Chaparro & J. P. Gisbert. (2014) Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Alimentary Pharmacology & Therapeutics 39:7, pages 645-659.
Crossref
Crossref
Cinzia Papadia, Joost Louwagie, Paolo Del Rio, Madeleine Grooteclaes, Alessandro Coruzzi, Chiara Montana, Marco Novelli, Cesare Bordi, Gian Luigi de’ Angelis, Paul Bassett, Joseph Bigley, Bryan Warren, Wendy Atkin & Alastair Forbes. (2014) FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia. Inflammatory Bowel Diseases 20:2, pages 271-277.
Crossref
Crossref
Maurice W. M. D. Lutgens, Martijn G. H. van Oijen, Geert J. M. G. van der Heijden, Frank P. Vleggaar, Peter D. Siersema & Bas Oldenburg. (2013) Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 19:4, pages 789-799.
Crossref
Crossref
Sverre Söderlund, Bernhard Tribukait, Åke Öst, Olle Broström, Per Karlén, Robert Löfberg, Johan Askling & Urban Sjöqvist. (2011) Colitis-associated DNA aneuploidy and dysplasia in Crohnʼs disease and risk of colorectal cancer. Inflammatory Bowel Diseases 17:5, pages 1101-1107.
Crossref
Crossref
Joel R. Pekow, Jeremy T. Hetzel, Jami A. Rothe, Stephen B. Hanauer, Jerrold R. Turner, John Hart, Amy Noffsinger, Dezheng Huo & David T. Rubin. (2010) Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflammatory Bowel Diseases 16:8, pages 1352-1356.
Crossref
Crossref
William Connell & Jarrad Wilson. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
518
527
.
Jane E. Onken. (2008) Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis?. Inflammatory Bowel Diseases 14:Supplement, pages S196-S197.
Crossref
Crossref
Jane E. Onken. (2008) Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis?. Inflammatory Bowel Diseases 14, pages S196-S197.
Crossref
Crossref
Jonathan Potack & Steven H. Itzkowitz. (2008) Colorectal Cancer in Inflammatory Bowel Disease. Gut and Liver 2:2, pages 61-73.
Crossref
Crossref
Robert Enns. (2008) Jumbo or large-capacity forceps for inflammatory bowel disease surveillance: is it truly important or just a marketing ploy?. Gastrointestinal Endoscopy 68:2, pages 279-282.
Crossref
Crossref
Peter Laszlo Lakatos & Laszlo Lakatos. (2008) Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World Journal of Gastroenterology 14:25, pages 3937.
Crossref
Crossref
F. Magro. 2008. Intestinal Inflammation and Colorectal Cancer. Intestinal Inflammation and Colorectal Cancer
17
24
.
Shigeo Yoshizawa, Katsuyoshi Matsuoka, Nagamu Inoue, Hiromasa Takaishi, Haruhiko Ogata, Yasushi Iwao, Makio Mukai, Tomonobu Fujita, Yutaka Kawakami & Toshifumi Hibi. (2007) Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis. Inflammatory Bowel Diseases 13:7, pages 865-873.
Crossref
Crossref
Charles N. Bernstein. (2006) Neoplasia in inflammatory bowel disease: Surveillance and management strategies. Current Gastroenterology Reports 8:6, pages 513-518.
Crossref
Crossref
Charles N. Bernstein. (2006) Biomarkers, Surveillance Strategies, Chromoendoscopy Medication-Induced Malignancies and Chemoprevention (Past). Inflammatory Bowel Diseases 12, pages S10-S11.
Crossref
Crossref
Charles N. Bernstein. (2006) Natural History and Management of Flat and Polypoid Dysplasia in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 35:3, pages 573-579.
Crossref
Crossref
Wolfram Goessling & Robert J. Mayer. (2006) Systemic Treatment of Patients Who Have Colorectal Cancer and Inflammatory Bowel Disease. Gastroenterology Clinics of North America 35:3, pages 713-727.
Crossref
Crossref
Edward V. LoftusJr.Jr.. (2006) Epidemiology and Risk Factors for Colorectal Dysplasia and Cancer in Ulcerative Colitis. Gastroenterology Clinics of North America 35:3, pages 517-531.
Crossref
Crossref